Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
SPORE in Prostate Cancer
Explore this Website
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
Home
About Us
Toggle About Us menu options
Affiliations
Donate
Resources
Job Opportunities
Contact Us
Research
Toggle Research menu options
Project 1
Project 2
Project 3
Project 4
Programs
Toggle Programs menu options
Career Enhancement Program
Toggle Career Enhancement Program menu options
2023 CEP Projects
Developmental Research Program
Toggle Developmental Research Program menu options
2023 DRP Awardee Projects
Cores
Toggle Cores menu options
Administrative Core
Biospecimen & Pathology
Computational Biology - Biostatistics
Investigators
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Research
Programs
Cores
Investigators
Publications
News
Home
Publications
Publications
Found 53 results
Author
Title
Type
Year
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Guo H
,
Ci X
,
Ahmed M
,
Hua JTony
,
Soares F
,
Lin D
,
Puca L
,
Vosoughi A
,
Xue H
,
Li E
et al.
. 2019.
ONECUT2 is a driver of neuroendocrine prostate cancer.
.
Nat Commun. 10(1):278.
K
Kolin DA
,
Kulm S
,
Elemento O
. 2020.
Clinical and Genetic Characteristics of Covid-19 Patients from UK Biobank.
.
medRxiv.
L
Lehmann GL
,
Hanke-Gogokhia C
,
Hu Y
,
Bareja R
,
Salfati Z
,
Ginsberg M
,
Nolan DJ
,
Mendez-Huergo SP
,
Dalotto-Moreno T
,
Wojcinski A
et al.
. 2020.
Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid.
.
J Exp Med. 217(6)
Li JJ
,
Shen MM
. 2019.
Prostate Stem Cells and Cancer Stem Cells.
.
Cold Spring Harb Perspect Med. 9(6)
Li JJ
,
Shen MM
. 2018.
Prostate Stem Cells and Cancer Stem Cells
.
Prostate Cancer.
Liu H
,
Murphy CJ
,
Karreth FA
,
Emdal KB
,
White FM
,
Elemento O
,
Toker A
,
Wulf GM
,
Cantley LC
. 2018.
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.
.
Cancer Discov. 8(3):354-369.
Liu D
,
Augello MA
,
Grbesa I
,
Prandi D
,
Liu Y
,
Shoag JE
,
R Karnes J
,
Trock BJ
,
Klein EA
,
Den RB
et al.
. 2021.
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
.
J Clin Invest. 131(10)
Liu D
,
Takhar M
,
Alshalalfa M
,
Erho N
,
Shoag J
,
Jenkins RB
,
Karnes J
,
Ross AE
,
Schaeffer EM
,
Rubin MA
et al.
. 2018.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
.
JCO Precision Oncology.
Liu D
,
Barbieri CE
,
Rubin MA
,
Demichelis F
,
Mosquera JMiguel
,
Elemento O
,
Sboner A
,
Shoag JE
,
Poliak D
,
Goueli RS
et al.
. 2020.
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.
.
Nat Commun. 11(1):1987.
Liu D
,
Takhar M
,
Alshalalfa M
,
Erho N
,
Shoag J
,
Jenkins RB
,
R Karnes J
,
Ross AE
,
Schaeffer EM
,
Rubin MA
et al.
. 2018.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
.
JCO Precis Oncol. 2018
Locallo A
,
Prandi D
,
Fedrizzi T
,
Demichelis F
. 2019.
TPES: tumor purity estimation from SNVs.
.
Bioinformatics. 35(21):4433-4435.
Loda M
,
Bastos DC
,
Ribeiro CF
,
Ahearn T
,
Nascimento J
,
Pakula H
,
Clohessy J
,
Mucci L
,
Roberts T
,
Zanata SM
et al.
. 2020.
Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss.
.
J Pathol.
N
Nowak DG
,
Katsenelson KCohen
,
Watrud KE
,
Chen M
,
Mathew G
,
D'Andrea VD
,
Lee MF
,
Swamynathan MMosur
,
Casanova-Salas I
,
Jibilian MC
et al.
. 2019.
The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.
.
J Cell Biol. 218(6):1943-1957.
P
Park K
,
Rubin MA
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
,
Tran H
,
Eng KW
,
Ramazanoglu S
,
Rolon RMMarrero
,
Scognamiglio T
et al.
. 2020.
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
.
Arch Pathol Lab Med. 144(12):1535-1546.
Penney KL
,
Tyekucheva S
,
Rosenthal J
,
Fandy HEl
,
Carelli R
,
Borgstein S
,
Zadra G
,
Fanelli GNicolò
,
Stefanizzi L
,
Giunchi F
et al.
. 2021.
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.
.
Mol Cancer Res. 19(3):475-484.
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
Puca L
,
Gavyert K
,
Sailer V
,
Conteduca V
,
Dardenne E
,
Sigouros M
,
Isse K
,
Kearney M
,
Vosoughi A
,
Fernandez L
et al.
. 2019.
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
.
Sci Transl Med. 11(484)
R
Ricker E
,
Verma A
,
Marullo R
,
Gupta S
,
Ye C
,
Pannellini T
,
Manni M
,
Tam W
,
Inghirami G
,
Elemento O
et al.
. 2020.
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma.
.
Sci Rep. 10(1):13094.
Robinson BD
,
Shen MM
,
Crowley L
,
Cambuli F
,
Aparicio L
,
Shibata M
,
Xuan S
,
Loda M
,
Li W
,
Hibshoosh H
et al.
. 2020.
A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors.
.
Elife. 9
Rubin MA
,
Beltran H
,
Ballman KV
,
Sboner A
,
Cyrta J
,
Demichelis F
,
Augspach A
,
De Filippo MRosaria
,
Prandi D
,
Thienger P
et al.
. 2020.
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
.
Nat Commun. 11(1):5549.
S
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2018.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer. 124(5):1008-1015.
Sailer V
,
Eng KWa
,
Zhang T
,
Bareja R
,
Pisapia DJ
,
Sigaras A
,
Bhinder B
,
Romanel A
,
Wilkes D
,
Sticca E
et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Salami SS
,
Hovelson DH
,
Kaplan JB
,
Mathieu R
,
Udager AM
,
Curci NE
,
Lee M
,
Plouffe KR
,
de la Vega LLazo
,
Susani M
et al.
. 2018.
Transcriptomic heterogeneity in multifocal prostate cancer.
.
JCI Insight. 3(21)
Shoag J
,
Liu D
,
Blattner M
,
Sboner A
,
Park K
,
Deonarine L
,
Robinson BD
,
Mosquera JMiguel
,
Chen Y
,
Rubin MA
et al.
. 2018.
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
.
J Clin Invest. 128(1):381-386.
« first
‹ previous
1
2
(current)
3
next ›
last »